These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 17310266

  • 1. Breast cancer leptomeningeal metastasis--the role of multimodality treatment.
    Rudnicka H, Niwińska A, Murawska M.
    J Neurooncol; 2007 Aug; 84(1):57-62. PubMed ID: 17310266
    [Abstract] [Full Text] [Related]

  • 2. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A, Rudnicka H, Murawska M.
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [Abstract] [Full Text] [Related]

  • 3. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
    Pan Z, Yang G, He H, Zhao G, Yuan T, Li Y, Shi W, Gao P, Dong L, Li Y.
    Int J Cancer; 2016 Oct 15; 139(8):1864-72. PubMed ID: 27243238
    [Abstract] [Full Text] [Related]

  • 4. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.
    Jo JC, Kang MJ, Kim JE, Ahn JH, Jung KH, Gong G, Kim HH, Ahn SD, Kim SS, Son BH, Ahn SH, Kim SB.
    Cancer Chemother Pharmacol; 2013 Jul 15; 72(1):201-7. PubMed ID: 23670641
    [Abstract] [Full Text] [Related]

  • 5. Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival.
    Chen TW, Jan IS, Chang DY, Lin CH, Chen IC, Chen HM, Cheng AL, Lu YS.
    J Neurooncol; 2020 May 15; 148(1):165-172. PubMed ID: 32346837
    [Abstract] [Full Text] [Related]

  • 6. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
    Fizazi K, Asselain B, Vincent-Salomon A, Jouve M, Dieras V, Palangie T, Beuzeboc P, Dorval T, Pouillart P.
    Cancer; 1996 Apr 01; 77(7):1315-23. PubMed ID: 8608509
    [Abstract] [Full Text] [Related]

  • 7. Leptomeningeal Metastasis in a Breast Cancer Treated with Two Lines of Intrathecal Chemotherapy - a Case Report.
    Mikudova V, Rejlekova K, Gyarfas J, Oravcova I, Chovanec M, Mardiak J, Mego M.
    Klin Onkol; 2019 Apr 01; 32(2):139-142. PubMed ID: 30995855
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
    Orlando L, Curigliano G, Colleoni M, Fazio N, Nole F, Martinelli G, Cinieri S, Graffeo R, Peruzzotti G, Goldhirsch A.
    Anticancer Res; 2002 Apr 01; 22(5):3057-9. PubMed ID: 12530042
    [Abstract] [Full Text] [Related]

  • 11. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
    Stemmler HJ, Mengele K, Schmitt M, Harbeck N, Laessig D, Herrmann KA, Schaffer P, Heinemann V.
    Anticancer Drugs; 2008 Sep 01; 19(8):832-6. PubMed ID: 18690096
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Intrathecal chemotherapy for leptomeningeal metastases in patients with breast cancer].
    Moskvina EA, Belov DM, Naskhletashvili DR, Mekheda LV, Bekyashev AK, Aleshin VA, Gasparyan TG, Mitrofanov AA, Sevyan NV, Prozorenko EV, Tkhazeplov AA, Roshchina KE.
    Zh Vopr Neirokhir Im N N Burdenko; 2024 Sep 01; 88(3):31-37. PubMed ID: 38881013
    [Abstract] [Full Text] [Related]

  • 14. Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy.
    Figura NB, Rizk VT, Mohammadi H, Evernden B, Mokhtari S, Yu HM, Robinson TJ, Etame AB, Tran ND, Liu J, Washington I, Diaz R, Czerniecki BJ, Soliman H, Han HS, Sahebjam S, Forsyth PA, Ahmed KA.
    Breast Cancer Res Treat; 2019 Jun 01; 175(3):781-788. PubMed ID: 30859348
    [Abstract] [Full Text] [Related]

  • 15. Treatment for meningeal carcinomatosis in breast cancer.
    Yap HY, Yap BS, Rasmussen S, Levens ME, Hortobagyi GN, Blumenschein GR.
    Cancer; 1982 Jul 15; 50(2):219-22. PubMed ID: 6177395
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Management of leptomeningeal metastasis in breast cancer.
    Assi HI, Mahmoud T, Saadeh FS, El Darsa H.
    Clin Neurol Neurosurg; 2018 Sep 15; 172():151-159. PubMed ID: 30015053
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Management of leptomeningeal malignancy.
    Pentheroudakis G, Pavlidis N.
    Expert Opin Pharmacother; 2005 Jun 15; 6(7):1115-25. PubMed ID: 15957966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.